Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for TrueBlue (TBI) over the last 17 years, with Q3 2025 value amounting to $7.3 million.

  • TrueBlue's Depreciation & Amortization (CF) rose 542.56% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year decrease of 324.74%. This contributed to the annual value of $29.6 million for FY2024, which is 1448.43% up from last year.
  • As of Q3 2025, TrueBlue's Depreciation & Amortization (CF) stood at $7.3 million, which was up 542.56% from $7.5 million recorded in Q2 2025.
  • In the past 5 years, TrueBlue's Depreciation & Amortization (CF) registered a high of $8.0 million during Q1 2024, and its lowest value of $6.2 million during Q3 2023.
  • Its 5-year average for Depreciation & Amortization (CF) is $7.0 million, with a median of $7.0 million in 2021.
  • Per our database at Business Quant, TrueBlue's Depreciation & Amortization (CF) plummeted by 2344.4% in 2021 and then skyrocketed by 2413.04% in 2024.
  • Quarter analysis of 5 years shows TrueBlue's Depreciation & Amortization (CF) stood at $7.2 million in 2021, then grew by 1.5% to $7.3 million in 2022, then decreased by 4.3% to $6.9 million in 2023, then decreased by 0.01% to $6.9 million in 2024, then increased by 5.76% to $7.3 million in 2025.
  • Its last three reported values are $7.3 million in Q3 2025, $7.5 million for Q2 2025, and $6.8 million during Q1 2025.